Improved Management of Soft Tissue Sarcomas Patients With an Optimized and Innovative Sorting Technology for Circulating Tumor Cells
NCT07401355 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-02-10
Summary
This trial is a monocentric, clinico-biological cohort study with prospective enrollment, aiming to develop a method for detecting and sorting CTCs (circulating tumour cells) from liquid biopsies (fresh blood samples) in patients with advanced or metastatic soft tissue sarcomas.This study include collection of clinical data, of tumor samples (collected during standard of care).
Conditions
- Diagnosis of Soft Tissue Sarcoma (STS)
Interventions
- OTHER
-
Collection of tumor and blood sample
Collection of tumor and blood sample for detecting and sorting circulating tumor cells
Sponsors & Collaborators
-
Centre Leon Berard
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-31
- Primary Completion
- 2030-01-31
- Completion
- 2030-01-31
Countries
- France
Study Locations
More Related Trials
-
Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB3 in Healthy Male Subjects
NCT02075073 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of LY2874455 in Participants With Advanced Cancer
NCT01212107 ·Status: COMPLETED ·Phase: PHASE1
-
Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
NCT05182164 ·Status: RECRUITING ·Phase: PHASE2
-
HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas
NCT05180695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)
NCT03855358 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas
NCT03899805 ·Status: COMPLETED ·Phase: PHASE2
-
Study of LYC-55716 in Adult Subjects With Locally Advanced or Metastatic Cancer
NCT02929862 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
NCT05711615 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma
NCT03126591 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Lapatinib in Combination With Caelyx in Patients With Advanced HER2 Positive Pretreated Breast Cancer
NCT02131506 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
NCT05852691 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 Negative
NCT02754011 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin
NCT00773344 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
NCT06841354 ·Status: RECRUITING ·Phase: PHASE3
-
A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers
NCT05091528 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer
NCT05509790 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study of LY3007113 in Participants With Advanced Cancer
NCT01463631 ·Status: COMPLETED ·Phase: PHASE1
-
Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)
NCT01333423 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of LY2875358 in Japanese Participants With Advanced Cancer
NCT01602289 ·Status: COMPLETED ·Phase: PHASE1
-
Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC
NCT06078384 ·Status: RECRUITING ·Phase: PHASE2
-
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
NCT05452213 ·Status: RECRUITING ·Phase: PHASE4
-
A Study in Patients With Advanced Breast Cancer
NCT04942054 ·Status: TERMINATED ·Phase: PHASE1
-
Targeting ATR in Soft-tissue Sarcomas
NCT04807816 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Clinical and Biologic Study of Secondary Cutaneous Effects in Targeted Cancer Therapies
NCT02517281 ·Status: COMPLETED ·Phase: NA
-
A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer
NCT04927481 ·Status: TERMINATED ·Phase: PHASE2